Ep. 155 Kevin McKernan on PCR testing for COVID-19
Our guest is Kevin McKernan, founder and chief scientific officer of Medicinal Genomics, a company specialized in genetic testing of medicinal plants, including cannabis for strains, traits, and pest infestation, including plant viruses. He is here to shed light on the process of PCR testing as applied to the COVID pandemic.
Kevin McKernan: Twitter
Note: The Accad and Koka Report participates in the Amazon Affiliate program and may earn a small commission from purchases completed from links on the website,
- Jaafar R. et al. “Correlation Between 3790 Quantitative Polymerase Chain Reaction–Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 Isolates” (Open access in Clinical Infectious Diseases)
WATCH ON YOUTUBE:
Watch the episode on our YouTube channel
SUPPORT THE SHOW:
Make a small donation on our Patreon page on and join our discussion group or receive a free book.
← Ep. 154 Outpatient COVID-19 Therapy: Why the Controversy?Ep. 156 The Push for Nurse Practitioners on the Frontlines of Healthcare →
Leave a Comment